How do spinal circuits mediating tactile sensation and pain get entangled to evoke allodynia, i.e., pain sensation, in response to a normally innocuous stimulus? Recent breakthroughs are now closing this long-standing, critical gap. VGLUT3-expressing neurons and their polysynaptic connectivity to calretinin-expressing neurons are now identified as key determinants of the spinal circuitry underlying mechanical allodynia.
Nature has created a strict delineation in our perception of light, innocuous touch and noxious, pain-evoking stimuli. Imagine if you were to feel pain upon the faintest of innocuous brush or touch. This disorder, termed allodynia, is exactly what chronic pain patients experience, particularly when it comes to chronic neuropathic pain, which is frequently therapy-resistant. It is not surprising therefore that the quest for the cause of allodynia has been one of the leading scientific questions for decades. Despite remarkable progress in our understanding of molecular mediators that govern activity across nociceptive pathways, the identity of cell types and circuits mediating allodynia has evaded clarification.
There is broad consensus that mechanisms underlying allodynia must operate at the level of functional reorganization of circuits, since pathways mediating touch and pain are segregated under normal physiological conditions (Figure 1,  top) . The spinal dorsal horn consists of morphologically and molecularly heterogeneous populations of neurons that receive, process, and transmit sensory information from periphery to the brain. C-and Ad-type peripheral nerve fibers transmit nociceptive signals to neurons in spinal lamina I and II, whereas Ab-type fibers, predominantly signaling innocuous touch, give input to both excitatory and inhibitory neurons in deeper spinal laminae, particularly lamina III (Figure 1,  top) . What, then, disrupts this segregated assembly to cause allodynia? While it is highly conceivable that these circuits structurally reorganize and reassemble as chronic pain progresses, it is known that allodynia can be evoked in healthy humans or rodents acutely by pharmacologically interfering with endogenous inhibitory control, i.e., too rapidly to account for structural remodeling. This suggests that pathways that link circuits mediating touch and pain are structurally already in place, but are masked by inhibition under physiological conditions. Indeed, strong evidence for this link was given by electrophysiological analyses in a landmark study by MacDermott and colleagues (Torsney and MacDermott, 2006) . While recent studies have helped understand the consequences of loss of gating via glycinergic neurons (Foster et al., 2015) or the benefits of enhancing inhibitory control by exogenously instilling precursors of GABAergic interneurons in the spinal cord (Brá z et al., 2012) , the nature of the circuits and molecular identities of neurons that cross-connect pathways mediating touch and pain have remained unknown.
Very recently, this field has progressed in leaps and bounds fostered by advances in mouse genetics, identification of markers for neuronal subtypes, and pharmacogenetics. Indeed, very recently, two seminal studies have unmasked the nature of spinal circuits mediating mechanical pain and mechanical allodynia (Duan et al., 2014; Peirs et al., 2015 , in this issue). Duan et al. (2014) reported the identity of neurons receiving Ab-fiber inputs in laminae II to be excitatory interneurons expressing somatostatin (SOM +ve neurons) that are structurally connected to projection neurons in lamina I, which then go on to transmit the message of ''pain'' to higher centers in the brain. Intriguingly, these SOM +ve neurons are held in check under physiological conditions by inhibitory neurons expressing dynorphin (Dyn +ve neurons) in lamina II, which receive inputs from Ab-fibers simultaneously as SOM +ve neurons, resulting in closing of the gate on the circuit linking touch and pain ( Figure 1 , bottom). While these findings provided key insights, one aspect that remained puzzling is that a majority of Ab-fiber inputs actually terminate in deeper laminae, e.g., lamina III, rather than in the superficial laminae I and II, indicating that certain important elements of the allodynia circuit were yet to be uncovered. A study published in this issue by Rebecca Seal and colleagues (Peirs et al., 2015) now fills this critical gap and unmasks the molecular identity of lamina III neurons receiving direct Ab-fiber inputs to be neurons expressing the glutamatergic transporter, VGLUT3 (Figure 1 , bottom). The premise of the study was an observation that Seal and colleagues made a few years earlier (Seal et al., 2009) , namely that mice lacking VGLUT3 are markedly impaired in their ability to develop mechanical allodynia and also show reduced sensing of mechanical pain. The authors correctly followed the maxim that uncovering the cell type to which this key phenotypic consequence can be attributed would lead the way to unraveling the circuit for mechanical allodynia. The present study represents a veritable tour de force in the elegant use of conditional gene deletion and systematic behavioral phenotyping coupled with modern methods of cell silencing as well as circuit mapping. The beauty of the approach is that the corresponding genetically encoded pharmacogenetic tools and tracers, respectively, targeted to specific cell types using an arsenal of specific Cre-driver lines (overview in Table 1 ). The first key finding revealed by the use of SNS-Cre, Advillin-Cre, KRT14-Cre, and Hoxb8-Cre mice was that the loss of VGLUT3 expression in the spinal cord, but in not peripheral sensory neurons, Merkel cells, or the brain, determines the loss of mechanical allodynia. Subsequently, within the spinal cord, the use of the Lbx1-Cre and Tlx3-Cre lines further narrowed down the locus to excitatory interneurons in the spinal dorsal horn. Deleting VGLUT3 in these neurons practically abrogated neuropathic or post-inflammatory mechanical allodynia specifically, leaving the thermal modality of nociception unaffected. These behavioral observations were supported by an elegant in vitro electrophysiology-based assay for studying allodynia, initially described by MacDermott and colleagues (Torsney and MacDermott, 2006) . Surprisingly, acute physiological pain caused by high-intensity mechanical stimuli was also reduced in these mice, although not as strongly as with the deletion of SOM +ve population neurons in the superficial spinal cord that was reported by Duan et al. (2014) (Figure 1, bottom) .
The Figure 1 , bottom) and other excitatory neurons in lamina III and IV, and via these make indirect connections to cells expressing PKCg (PKCg +ve ), the adult calretinin-expressing population (CR +ve ), and inhibitory neurons in lamina II and III (Figure 1, bottom) .
At this juncture, it is crucial to work out whether VGLUT3 protein as such is required for the development of mechanical allodynia or whether it is the functional nature of the VGLUT3 +ve neuron that imparts the ability to develop mechanical Finally, the authors have observed some differences in cFOS activation profiles of VGLUT3-target neurons in conditions of inflammatory versus neuropathic pain versus nerve injury model. While the concept is very interesting and conceivable, the data indicate small differences in activation profiles of different populations involved and, given especially that they originate from DREADD-based stimulation of only a subpopulation of VGLUT3 +ve cells, merit a cautious interpretation and further validation.
In summary, this seminal work has identified VGLUT3 +ve neurons and their polysynaptic connectivity to CR +ve neurons as key determinants of mechanical allodynia. While this represents a significant advance in our understanding of the spinal circuitry mediating allodynia and mechanically evoked pain, it also raises several new questions. At the forefront, it remains unclear how the two apparently distinct circuits described by Duan et al. (2014) and Peirs et al. (2015) , originating in lamina II and lamina III, respectively, come together to yield allodynia. Given the identical requirement of each population for mechanical allodynia, cross-talk between these circuits and convergence on common elements is likely, if not obligatory. For example, it is conceivable that vertical cells in lamina II, which were reported by Peirs et al. (2015) to directly receive inputs from the VGLUT3 +ve population, are identical to the SOM +ve neurons described by Duan et al. (2014) better understanding of where exactly they are positioned in the circuitry and how they putatively convey information regarding innocuous touch onto painspecific projection neurons in lamina I. While this study has uncovered several highly interesting characteristics of the VGLUT3 +ve cell population in the spinal cord, more work will be needed in future studies to pinpoint the precise functional connectivity. In particular, given that allodynia does not come about in physiological (naive) conditions, it follows that the VGLUT3 +ve population is normally under strong inhibitory control. What is the identity of inhibitory neurons that control the activity of VGLUT3 +ve neurons, and how is this circuit reconciled with current knowledge on the placement and role of GABAergic and glycinergic inhibitory interneurons? Retrograde tracing studies will be very helpful in this regard.
Further studies are also required to delineate and differentially understand the functional role of VGLUT3 +ve cell population versus VGLUT3 protein in modulating the sensitivity to painful and innocuous mechanical inputs. Complementing studies on artificial activation of cell populations with studies in which these cell populations are ablated, or better still, reversibly and selectively silenced in post-developmental stages via implementation of inhibitory DREADDs or optogenetic approaches in adult mice, would be helpful. Finally, this study has clarified that VGLUT3 expression in C-low threshold mechanoceptors, the only cell population of the peripheral afferent-spinal cord circuitry in which VGLUT3 expression is preserved in adult mice, is not required for mechanical allodynia. However, it is important to note that this does not negate the potential importance of this interesting population of peripheral sensory neurons in propagating pain and allodynia under pathological pain conditions. Taken together, there is much excitement about recent breakthroughs in our understanding of a clinical problem that has long evaded therapy, and the field is on an excellent path toward solving the puzzle of neuropathic allodynia. 
